Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ocular Therapeutix
Biotech
BMS snags top neuro researcher from Eisai—Chutes & Ladders
BMS snags top neuro researcher from Eisai. Juvena co-founder jumps from CEO post. Amgen commercial vet climbs to Spyre.
Darren Incorvaia
,
Zoey Becker
Jan 23, 2026 8:30am
Flagship-backed biotechs name new leaders—Chutes & Ladders
Nov 15, 2024 8:30am
Exscientia fires CEO—Chutes & Ladders
Feb 16, 2024 9:30am
Forte taps new exec amid shareholder dissent—Chutes & Ladders
Jun 10, 2022 9:30am
Ocular's drug-eluting insert for dry eye disease misses endpoint
Oct 22, 2021 11:09am
Ocular's drug insert just misses bull's-eye in glaucoma trial
May 21, 2019 9:53am
